Evidence map›Paper›PMID 27381756›Full record

ArticleJournal of the American Heart Association2016

Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.

Christian Veltmann, Hector Barajas-Martinez, Christian Wolpert, Martin Borggrefe, Rainer Schimpf, Ryan Pfeiffer, Gabriel Cáceres, Elena Burashnikov, Charles Antzelevitch, Dan Hu

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Observational
  2. Article
  3. Phenotypic expression of rare progressive cardiac conduction disease variants in the general population.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Human Genetics of Cardiac Arrhythmias.Advances in experimental medicine and biology · 2024
    Review
  8. Multi-site validation of a functional assay to adjudicatemedRxiv : the preprint server for health sciences · 2023
    Article
  9. Functional Characterisation of the RareInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Christian VeltmannRhythmology and Electrophysiology, Department of Cardiology and Angiology Hannover Medical School, Hannover, Germany.
Hector Barajas-MartinezMolecular Genetic Department, Masonic Medical Research Laboratory, Utica, NY, USA.
Christian WolpertKlinik für Innere Medizin, Cardiology Klinikum Ludwigsburg, Ludwigsburg, Germany.
Martin Borggrefe1st Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany DZHK partner site Heidelberg/Mannheim, Mannheim, Germany.
Rainer Schimpf1st Department of Medicine-Cardiology, University Medical Centre Mannheim, Mannheim, Germany DZHK partner site Heidelberg/Mannheim, Mannheim, Germany.
Ryan PfeifferMolecular Genetic Department, Masonic Medical Research Laboratory, Utica, NY, USA.
Gabriel CáceresMolecular Genetic Department, Masonic Medical Research Laboratory, Utica, NY, USA.
Elena BurashnikovMolecular Genetic Department, Masonic Medical Research Laboratory, Utica, NY, USA.
Charles AntzelevitchLankenau Institute for Medical Research, Philadelphia, USA dianah@mmrl.edu cantzelevitch@gmail.com.
Dan HuMolecular Genetic Department, Masonic Medical Research Laboratory, Utica, NY, USA dianah@mmrl.edu cantzelevitch@gmail.com.
Masonic Medical Research Laboratory · USUniversity Medical Centre Mannheim · DEKlinikum Ludwigsburg · DELankenau Institute for Medical Research · USMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhenotypic overlap of type 3 long QT syndrome (LQT3), Brugada syndrome (BrS), cardiac conduction disease (CCD), and sinus node dysfunction (SND) is observed with SCN5A mutations. SCN5A-E1784K is the most common mutation associated with BrS and LQTS3. The present study examines the genotype-phenotype relationship in a large family carrying SCN5A-E1784K and SCN5A-H558R polymorphism. METHODS AND

resultsClinical work-up, follow-up, and genetic analysis were performed in 35 family members. Seventeen were SCN5A-E1784K positive. They also displayed QTc prolongation, and either BrS, CCD, or both. One carrier exhibited SND. The presence of SCN5A-H558R did not significantly alter the phenotype of SCN5A-E1784K carriers. Fourteen SCN5A-E1784K patients underwent implantable cardioverter-defibrillator (ICD) implantation; 4 developed VF and received appropriate ICD shocks after 8±3 months of follow-up. One patient without ICD also developed VF after 6.7 years. These 5 cases carried both SCN5A-E1784K and SCN5A-H558R. Functional characterization was achieved by expressing SCN5A variants in TSA201 cells. Peak (INa,P) or late (INa,L) sodium currents were recorded using whole-cell patch-clamp techniques. Co-expression of SCN5A-E1784K and SCN5A-WT reduced INa,P to 70.03% of WT, shifted steady-state inactivation by -11.03 mV, and increased INa,L from 0.14% to 1.86% of INa,P. Similar changes were observed when SCN5A-E1784K was co-expressed with SCN5A-H558R.

conclusionsWe demonstrate a strong genotype-phenotype correlation with complete penetrance for BrS, LQTS, or CCD in the largest family harboring SCN5A-E1784K mutation described so far. Phenotype of LQTS is present during all decades of life, whereas CCD develops with increasing age. Phenotypic overlap may explain the high event rate in carriers.

Indexed as

AdolescentAdultBrugada SyndromeCardiac Conduction System DiseaseChildDefibrillators, ImplantableDisease ManagementFamilyFemaleGenotypeHumansLong QT SyndromeMaleMiddle AgedNAV1.5 Voltage-Gated Sodium ChannelPatch-Clamp TechniquesNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanBrugada syndromechannelopathiesconduction defectelectrophysiologygeneticslong QT syndrome

Identifiers

PMID27381756
PMCPMC5015375
OpenAlexW2462039470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.